Cullen Capital Management
$10.2B 13F equity value
223 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Cullen Capital Management covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| NVS | Novartis AG (ADR) | 2,033,040 | $319M | 3.1% |
| CSCO | Cisco Systems Inc. | 2,557,662 | $300M | 3.0% |
| MS | Morgan Stanley | 1,413,521 | $295M | 2.9% |
| JNJ | Johnson & Johnson | 1,099,077 | $279M | 2.7% |
| C | Citigroup Inc. | 1,929,255 | $270M | 2.7% |
| JPM | JP Morgan Chase & Co. | 810,780 | $265M | 2.6% |
| MRK | Merck & Co. Inc. | 2,016,795 | $259M | 2.5% |
| BAC | Bank of America Corp. | 4,335,818 | $247M | 2.4% |
| DUK | Duke Energy Corp. | 1,933,412 | $245M | 2.4% |
| JCI | Johnson Controls International | 1,671,438 | $244M | 2.4% |
Track Cullen Capital Management's 13F portfolio: $10.2B in reported holdings, 223 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}